ArticleAdvances in radiation oncology2025
Variable Relative Biological Effectiveness of Protons in the Rat Spinal Cord: Measurements and Comparison With Model Calculations.
Article in Advances in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tissue-level RBE determination and normal lung responses along the proton SOBP.Radiation oncology (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To determine the relative biological effectiveness (RBE) in the rat spinal cord after 6 fractions of protons as a function of linear energy transfer (LET) and dose. Methods and Materials: The rat spinal cord was irradiated at 4 different positions of a 6 cm spread-out Bragg peak using 6 fractions of protons (LET: 1.4, 2.7, 3.9, and 5.5 keV/µm). Dose-response curves were established for the endpoint paresis grade 2, and the RBE was calculated based on the dose at 50% effect probability. Including data with single and split doses, the measured RBE values were compared with predictions from 4 mechanistic, 3 phenomenological, and 2 patient-derived variable RBE models. Results: With increasing LET, the dose at 50% effect probability decreased from 51.3 Gy to 43.3 Gy, resulting in a rise in the RBE from 1.11 to 1.32. The biologically equivalent dose decreased markedly between the 2 proximal and 2 distal spinal cord positions, resulting in extrapolated maximum RBE values of up to 1.87 in the limit of zero dose per fraction. The α/β values ranged between 1.5 Gy and 4.2 Gy. At 3.9 and 5.5 keV/µm, the RBE increased with decreasing dose, and at 1.8 Gy per fraction, the RBE was extrapolated to 1.40 and 1.42, respectively. The agreement between predicted and measured RBE varied between the different models. Conclusions: A fixed RBE of 1.1 provides a good approximation up to the center of the spread-out Bragg peak; however, at 3 mm from the distal end, the RBE increases markedly and may reach values above 1.4 at clinical fraction schedules. Using predictions from a variable RBE model may, therefore, be reasonable; however, the model and model parameters should be carefully selected, ideally as a consensus among the proton therapy centers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.